PE20110933A1 - Productos probioticos infantiles - Google Patents
Productos probioticos infantilesInfo
- Publication number
- PE20110933A1 PE20110933A1 PE2011000453A PE2011000453A PE20110933A1 PE 20110933 A1 PE20110933 A1 PE 20110933A1 PE 2011000453 A PE2011000453 A PE 2011000453A PE 2011000453 A PE2011000453 A PE 2011000453A PE 20110933 A1 PE20110933 A1 PE 20110933A1
- Authority
- PE
- Peru
- Prior art keywords
- source
- children
- lcpufa
- acid
- polyinsaturated
- Prior art date
Links
- 239000006041 probiotic Substances 0.000 title abstract 2
- 230000000529 probiotic effect Effects 0.000 title abstract 2
- 235000018291 probiotics Nutrition 0.000 title abstract 2
- 241000917009 Lactobacillus rhamnosus GG Species 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- 229940059406 lactobacillus rhamnosus gg Drugs 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 235000016709 nutrition Nutrition 0.000 abstract 2
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 abstract 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 abstract 1
- 241000894006 Bacteria Species 0.000 abstract 1
- 241001608472 Bifidobacterium longum Species 0.000 abstract 1
- 206010012735 Diarrhoea Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 206010033078 Otitis media Diseases 0.000 abstract 1
- 206010057190 Respiratory tract infections Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000007815 allergy Effects 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 229940009291 bifidobacterium longum Drugs 0.000 abstract 1
- 235000014633 carbohydrates Nutrition 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 abstract 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 abstract 1
- 235000019197 fats Nutrition 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 150000004668 long chain fatty acids Chemical class 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/533—Longum
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pediatric Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Dairy Products (AREA)
Abstract
REFERIDA A UNA FORMULACION NUTRICIONAL QUE COMPRENDE UNA FUENTE DE PROTEINA, UNA FUENTE DE GRASA, UNA FUENTE DE CARBOHIDRATOS, UNA BACTERIA PROBIOTICA TAL COMO BIFIDOBACTERIUM LONGUM AH1206 EN UN RANGO DE 1x10^4 CFU A 1x10^10 POR GRAMO DE LA FORMULA, UN PROBIOTICO ADICIONAL TAL COMO LACTOBACILLUS RHAMNOSUS GG (LGG), POR LO MENOS UN ACIDO GRASO POLIINSATURADO DE CADENA LARGA (LCPUFA) TAL COMO ACIDO ARAQUIDONICO (ARA) Y ACIDO DOCOSAHEXAENOICO (DHA) Y UN PREBIOTICO TAL COMO LACTULOSA, INULINA, POLIDEXTROSA, LACTOSACAROSA, ENTRE OTROS. DICHA FORMULACION ES UTIL EN LA ALIMENTACION DE LACTANTES, COMO PRODUCTO NUTRICIONAL PARA NINOS Y REDUCE Y/O PREVIENE INFLAMACIONES EN ENFERMEDADES TALES COMO ALERGIAS, ASMA, DIARREA, INFECCIONES RESPIRATORIAS Y OTITIS MEDIA
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/284,208 US20100074870A1 (en) | 2008-09-19 | 2008-09-19 | Probiotic infant products |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20110933A1 true PE20110933A1 (es) | 2012-01-29 |
Family
ID=42037893
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2011000453A PE20110933A1 (es) | 2008-09-19 | 2009-09-18 | Productos probioticos infantiles |
Country Status (15)
Country | Link |
---|---|
US (1) | US20100074870A1 (es) |
EP (1) | EP2323493B8 (es) |
CN (1) | CN102159086B (es) |
BR (1) | BRPI0919173A2 (es) |
CA (1) | CA2737805A1 (es) |
CZ (1) | CZ2011139A3 (es) |
ES (1) | ES2398189T3 (es) |
HK (2) | HK1158025A1 (es) |
MX (1) | MX2011002238A (es) |
NO (1) | NO20110170A1 (es) |
PE (1) | PE20110933A1 (es) |
PL (1) | PL2323493T3 (es) |
RU (1) | RU2520085C2 (es) |
TW (1) | TW201016145A (es) |
WO (1) | WO2010033775A1 (es) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8498729B2 (en) | 2008-08-29 | 2013-07-30 | Smp Logic Systems Llc | Manufacturing execution system for use in manufacturing baby formula |
CA2761444C (en) * | 2009-05-11 | 2018-04-24 | Nestec S.A. | Lactobacillus johnsonii la1 ncc533 (cncm i-1225) and immune disorders |
US9375028B2 (en) | 2010-12-09 | 2016-06-28 | Mead Johnson Nutrition Company | Compositions and methods for nutrient delivery |
CN102899261B (zh) * | 2011-03-11 | 2016-12-07 | 光晟生物科技股份有限公司 | 长双歧杆菌长亚种br022菌株的用途 |
WO2012154738A1 (en) * | 2011-05-09 | 2012-11-15 | The Cleveland Clinic Foundation | Composition and method to improve intestinal health |
GB201112091D0 (en) | 2011-07-14 | 2011-08-31 | Gt Biolog Ltd | Bacterial strains isolated from pigs |
GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
CN103798392B (zh) * | 2014-03-07 | 2015-12-30 | 内蒙古伊利实业集团股份有限公司 | 具有缓解咽喉部炎症功效的益生菌食品组合物及食品 |
US20160016002A1 (en) * | 2014-07-17 | 2016-01-21 | John Todd Kuenstner | Treatment of Diseases Using Combination of Ultraviolet Blood Irradiation and Probiotics |
WO2016102951A1 (en) | 2014-12-23 | 2016-06-30 | 4D Pharma Research Limited | Pirin polypeptide and immune modulation |
ME02997B (me) | 2014-12-23 | 2018-10-20 | 4D Pharma Res Ltd | Soj bacteroides thetaiotaomicron i njegova upotreba u smanjenju inflamacije |
MA41010B1 (fr) | 2015-06-15 | 2020-01-31 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
MD3307288T2 (ro) | 2015-06-15 | 2019-12-31 | 4D Pharma Res Ltd | Compoziții care conțin tulpini bacteriene |
PL3206700T3 (pl) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Kompozycje zawierające szczepy bakteryjne |
CN115364122A (zh) | 2015-06-15 | 2022-11-22 | 4D制药研究有限公司 | 包含细菌菌株的组合物 |
MA41060B1 (fr) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
EA034677B1 (ru) | 2015-11-20 | 2020-03-05 | 4Д Фарма Рисёрч Лимитед | Композиции для лечения или профилактики рака, содержащие штамм enterococcus gallinarum |
GB201520497D0 (en) | 2015-11-20 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB201520638D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB201520631D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB201612191D0 (en) | 2016-07-13 | 2016-08-24 | 4D Pharma Plc | Compositions comprising bacterial strains |
DK3313423T3 (da) | 2016-03-04 | 2019-05-20 | 4D Pharma Plc | Sammensætninger omfattende bakterielle blautia-stammer til behandling af visceral hypersensitivitet |
TWI802545B (zh) | 2016-07-13 | 2023-05-21 | 英商4D製藥有限公司 | 包含細菌菌株之組合物 |
GB201621123D0 (en) | 2016-12-12 | 2017-01-25 | 4D Pharma Plc | Compositions comprising bacterial strains |
LT3630136T (lt) | 2017-05-22 | 2021-06-10 | 4D Pharma Research Limited | Kompozicijos, apimančios bakterines padermes |
WO2018215782A1 (en) | 2017-05-24 | 2018-11-29 | 4D Pharma Research Limited | Compositions comprising bacterial strain |
HUE052258T2 (hu) | 2017-06-14 | 2021-04-28 | 4D Pharma Res Ltd | Megasphaera nemzetségbe tartozó baktériumtörzset tartalmazó készítmény, és alkalmazása |
EP3638271B1 (en) | 2017-06-14 | 2020-10-14 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
IL283973B (en) | 2017-06-14 | 2022-08-01 | 4D Pharma Res Ltd | Preparations containing bacterial strains |
CN111227049B (zh) * | 2018-11-29 | 2022-08-12 | 内蒙古伊利实业集团股份有限公司 | 一种维持褐色植物基酸奶货架期内组织状态稳定性的方法 |
CN109652349B (zh) * | 2019-02-25 | 2021-03-02 | 江南大学 | 一株能够缓解特应性皮炎的长双歧杆菌及其应用 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5843698A (en) * | 1997-04-30 | 1998-12-01 | Universal Ventures | Deleteriously affecting members of a target species by exposure to a component of symbiont or food source of an adjoiner species that is symbiotic with the target species |
US5902743A (en) * | 1998-03-20 | 1999-05-11 | Wisconsin Alumni Research Foundation | Probiotic bifidobacterium strain |
ID29150A (id) * | 1999-01-15 | 2001-08-02 | Entpr Ireland Cs | Penggunaan lactobacillus salivarius |
US6074815A (en) * | 1999-03-08 | 2000-06-13 | Universal Ventures | Selection of test species for testing to identify components thereof that deleteriously affect a target species member |
US20040161422A1 (en) * | 1999-04-30 | 2004-08-19 | Natarajan Ranganathan | Nutritional compositions comprising probiotics |
US6150127A (en) * | 1999-11-30 | 2000-11-21 | Universal Ventures | Causing a desirable change in a behavior pattern |
US7179460B2 (en) * | 2002-12-05 | 2007-02-20 | Danisco A/S | Bacterial composition and its use |
US20070031537A1 (en) * | 2003-06-23 | 2007-02-08 | Marie-Cristene Secretin | Infant or follow-on formula |
NZ544642A (en) * | 2003-06-23 | 2009-01-31 | Nestec Sa | Infant or follow-on formula |
RU2264451C2 (ru) * | 2003-10-08 | 2005-11-20 | Закрытое Акционерное Общество "Биокад" | Биопрепарат "бифистим от 3 месяцев до 3 лет" для профилактики и лечения дисбактериозов и инфекционнных болезней желудочно-кишечного тракта у детей в возрасте от 3 месяцев до 3 лет, биологически активная добавка к пище "бифистим от 3 месяцев до 3 лет" для профилактики дисбактериозов и восстановления микрофлоры желудочно-кишечного тракта после антибиотикотерапии и других неблагоприятных воздействий у детей в возрасте от 3 месяцев до 3 лет и консорциум бифидобактерий для коррекции микрофлоры желудочно-кишечного тракта у детей в возрасте от 3 месяцев до 3 лет |
EP1750674A4 (en) * | 2004-05-27 | 2012-05-23 | Advanced Bionutrition Corp | MICROPARTICLES FOR THE ORAL LEVY |
WO2007039596A1 (en) * | 2005-10-05 | 2007-04-12 | Nestec S.A. | Nutritional formulation for promoting catch-up growth |
MY148872A (en) * | 2006-02-15 | 2013-06-14 | Nestec Sa | Use of bifidobacterium longum for the prevention and treatment of inflammation |
JP5538209B2 (ja) * | 2007-03-28 | 2014-07-02 | アリメンタリー・ヘルス・リミテッド | プロバイオティック性のビフィドバクテリウム菌株 |
-
2008
- 2008-09-19 US US12/284,208 patent/US20100074870A1/en not_active Abandoned
-
2009
- 2009-09-18 ES ES09815248T patent/ES2398189T3/es active Active
- 2009-09-18 EP EP09815248A patent/EP2323493B8/en not_active Not-in-force
- 2009-09-18 WO PCT/US2009/057434 patent/WO2010033775A1/en active Application Filing
- 2009-09-18 CZ CZ20110139A patent/CZ2011139A3/cs unknown
- 2009-09-18 CA CA2737805A patent/CA2737805A1/en not_active Abandoned
- 2009-09-18 PE PE2011000453A patent/PE20110933A1/es not_active Application Discontinuation
- 2009-09-18 PL PL09815248T patent/PL2323493T3/pl unknown
- 2009-09-18 MX MX2011002238A patent/MX2011002238A/es not_active Application Discontinuation
- 2009-09-18 RU RU2011115228/10A patent/RU2520085C2/ru not_active IP Right Cessation
- 2009-09-18 BR BRPI0919173A patent/BRPI0919173A2/pt not_active IP Right Cessation
- 2009-09-18 CN CN2009801366582A patent/CN102159086B/zh not_active Expired - Fee Related
- 2009-09-18 TW TW098131601A patent/TW201016145A/zh unknown
-
2011
- 2011-02-01 NO NO20110170A patent/NO20110170A1/no not_active Application Discontinuation
- 2011-11-25 HK HK11112842.2A patent/HK1158025A1/xx not_active IP Right Cessation
-
2012
- 2012-02-10 HK HK12101363.3A patent/HK1160730A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP2323493B1 (en) | 2012-10-24 |
CA2737805A1 (en) | 2010-03-25 |
EP2323493A1 (en) | 2011-05-25 |
WO2010033775A1 (en) | 2010-03-25 |
TW201016145A (en) | 2010-05-01 |
MX2011002238A (es) | 2011-04-05 |
RU2520085C2 (ru) | 2014-06-20 |
BRPI0919173A2 (pt) | 2019-09-24 |
RU2011115228A (ru) | 2012-10-27 |
PL2323493T3 (pl) | 2013-03-29 |
US20100074870A1 (en) | 2010-03-25 |
CN102159086A (zh) | 2011-08-17 |
EP2323493A4 (en) | 2011-09-21 |
NO20110170A1 (no) | 2011-03-30 |
CN102159086B (zh) | 2013-03-06 |
CZ2011139A3 (cs) | 2011-09-07 |
HK1158025A1 (en) | 2012-07-13 |
HK1160730A1 (en) | 2012-08-17 |
ES2398189T3 (es) | 2013-03-14 |
EP2323493B8 (en) | 2012-12-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20110933A1 (es) | Productos probioticos infantiles | |
PE20110932A1 (es) | Productos probioticos infantiles | |
WO2010096564A3 (en) | Dietary supplements containing polyunsaturated omega-3 fatty acids and probiotic bacteria with potential gastrointestinal and dermatological benefits | |
PE20110592A1 (es) | Compuestos nutricionales para promover el desarrollo de la salud y el crecimiento | |
PE20121406A1 (es) | Cepas de lactobacillus plantarum como agentes hipocolesterolemicos | |
NZ601141A (en) | Nutritional formulas containing synbiotics | |
MY150459A (en) | Infant formula with probiotics | |
BR112016018013A2 (pt) | Preparação e incorporação de coprodutos em bebidas para alcançar benefícios de saúde metabólica e do tubo digestivo | |
IN2014DN03449A (es) | ||
AR076676A1 (es) | Lactobacillus johnsonii la1 ncc533 (cncm i-1225) y trastornos inmunes | |
NZ613165A (en) | Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated fatty acids and uses thereof | |
BR112013028705A2 (pt) | cepas bacterianas probióticas e composição simbiótica contendo as mesmas destinadas a alimentos para lactentes | |
BRPI1011089A8 (pt) | Composição nutricional para estimular o desenvolvimento e a função cerebral de crianças. | |
CL2011003078A1 (es) | Uso de una composicion nutricional para mantener, sostener y/o mejorar el desempeno cognitivo en un nino de 3 a 6 anos, que comprende al menos una fuente de proteina, una fuente de carbohidratos, una fuente de lipido, un microorganismo probiotico, y prebioticos, en donde la fuente de lipido comprende acido docosahexanoico (dha). | |
PH12014502811B1 (en) | Dietary management of celiac disease and food allergy | |
AR087969A1 (es) | Composiciones nutricionales parcialmente hidrolizadas de caseina-suero para reducir la aparicion de alergias | |
MX2019005343A (es) | Composiciones nutricionales que proporcionan manejo dietetico de colicos. | |
PH12016500271A1 (en) | Probiotic for infantile excessive crying | |
EE201500006A (et) | Isoleeritud mikroorganismi tüvi Lactobacillus gasseri MCC2 DSM 23882 ning selle kasutamine | |
WO2006109194A3 (en) | Chromium-fatty acid compounds and methods of making and using thereof | |
CO2021008245A2 (es) | Producto alimenticio con efecto inmunomodulador | |
MY159390A (en) | Nutritional composition for infants | |
MX355787B (es) | Cepas de lactococcus lactis y preparaciones bacterianas de las mismas, para la producción de péptidos bioactivos que tienen efectos antihipertensivos y de disminución de colesterol en mamíferos; productos nutricionales y terapéuticos producidos a partir de los mismos. | |
ATE536102T1 (de) | Probiotischer stamm von lactobacillus delbrueckii subsp bulgaricus | |
GR20110100600A (el) | Λειτουργικες επιτραπεζιες ελιες ζυμωμενες με γαλακτικα βακτηρια που διαθετουν προβιοτικες ιδιοτητες |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |